全文获取类型
收费全文 | 1174篇 |
免费 | 139篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 96篇 |
妇产科学 | 17篇 |
基础医学 | 98篇 |
口腔科学 | 44篇 |
临床医学 | 104篇 |
内科学 | 363篇 |
皮肤病学 | 29篇 |
神经病学 | 23篇 |
特种医学 | 189篇 |
外科学 | 66篇 |
综合类 | 101篇 |
预防医学 | 82篇 |
眼科学 | 9篇 |
药学 | 73篇 |
中国医学 | 3篇 |
肿瘤学 | 56篇 |
出版年
2024年 | 3篇 |
2023年 | 16篇 |
2022年 | 13篇 |
2021年 | 24篇 |
2020年 | 23篇 |
2019年 | 8篇 |
2018年 | 19篇 |
2017年 | 43篇 |
2016年 | 37篇 |
2015年 | 29篇 |
2014年 | 63篇 |
2013年 | 72篇 |
2012年 | 27篇 |
2011年 | 26篇 |
2010年 | 63篇 |
2009年 | 68篇 |
2008年 | 27篇 |
2007年 | 64篇 |
2006年 | 35篇 |
2005年 | 31篇 |
2004年 | 30篇 |
2003年 | 19篇 |
2002年 | 14篇 |
2001年 | 29篇 |
2000年 | 13篇 |
1999年 | 18篇 |
1998年 | 77篇 |
1997年 | 64篇 |
1996年 | 59篇 |
1995年 | 50篇 |
1994年 | 46篇 |
1993年 | 42篇 |
1992年 | 12篇 |
1991年 | 5篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 24篇 |
1987年 | 14篇 |
1986年 | 19篇 |
1985年 | 17篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1976年 | 12篇 |
1975年 | 9篇 |
排序方式: 共有1362条查询结果,搜索用时 15 毫秒
991.
Autosomal dominant hyper IgE (HIES or Job's) syndrome is a rare primary immune deficiency characterized by eczema, recurrent skin and lung infections, extremely elevated serum IgE, and a variety of connective tissue and skeletal abnormalities. Individuals with HIES share a characteristic facial appearance and many oral manifestations including retained primary dentition, a high arched palate, variations of the oral mucosa and gingiva, and recurrent oral candidiasis. Mutations in STAT3 account for the majority, if not all, of the cases of autosomal dominant HIES, but the pathogenesis of the many varied features remains poorly understood. In this review, we discuss the clinical phenotype of HIES including immunologic and non-immunologic features, the genetics of HIES, and treatment. 相似文献
992.
Pera A; Seevers RH; Meyer K; Hall C; Bekerman C; Anderson TM; Katzen H; Laakso L; Pinsky SM 《Radiology》1985,156(3):783-786
We developed and evaluated a new procedure for imaging gastric ulcer disease with technetium 99m-labeled sucralfate. The new method employs direct in vivo labeling of sucralfate instead of in vitro labeling using human serum albumin, as previously reported in the literature. Tests using hydrochloric acid and a rabbit ulcer model showed the efficacy of the direct in vivo labeling technique and the ability of the tagged material to bind to ulcers, respectively. In 26 studies using humans with sucralfate labeled directly in vivo, 15 gave true-negative results and 11 gave true-positive results. Of 14 studies using humans with in vitro labeled sucralfate, three gave true-negative results, three gave true-positive results, and the results of eight were either false-negative or could not be interpreted because of high levels of activity remaining in the stomach. We suggest that the direct in vivo labeling method significantly improves the sucralfate gastric ulcer imaging technique. 相似文献
993.
Impact of aggressive management and palliative care on cancer costs in the final month of life 下载免费PDF全文
994.
Taishi Hirai MD J. Aaron Grantham MD David E. Kandzari MD William Ballard MD W. Morris Brown MD Keith B. Allen MD Ajay J. Kirtane MD SM Michael Argenziano MD Robert W. Yeh MD MSc Kamal Khabbaz MD William Lombardi MD John Lasala MD Puja Kachroo MD Dimitri Karmpaliotis MD PhD Kensey L. Gosch MS Adam C. Salisbury MD MSc the OPTIMUM Study Group 《Catheterization and cardiovascular interventions》2023,102(5):814-822
995.
996.
Olivier F. Bertrand Éric Larose DVM MD Josep Rodés-Cabau MD Stéphane Rinfret MD SM Jean-Pierre Déry MD MSc Rodrigo Bagur MD Onil Gleeton MD Can M. Nguyen MD Guy Proulx MD Robert De Larochellière MD Paul Poirier MD PhD Olivier Costerousse PhD Louis Roy MD 《The American journal of cardiology》2010,106(2):155-161
997.
补肾补骨汤治疗绝经后骨质疏松症的疗效及分子机制 总被引:5,自引:0,他引:5
目的:明确补肾补骨汤(BuShenBuGuTang,BSBGT)治疗绝经后骨质疏松症的分子机制。方法:SD成年雌鼠分为阴性对照组、去势组、中药治疗组和雌激素治疗组4组,12周后检测4组骨密度、骨形态计量学参数及I型胶原的变化并比较各组间差异。体外实验采用大鼠骨髓基质细胞的原代培养体系,加用不同药物处理后,用半定量RT-PCR方法检测破骨细胞分化因子和护骨因子的变化情况。结果:补肾补骨汤对SD大鼠上述3项指标的维持具有明显的效果,而且在体外可明显地抑制破骨细胞分化因子的表达和促进护骨因子的表达。结论:补肾补骨汤对于绝经后骨质疏松症有明显的治疗作用,是通过调节破骨细胞分化因子和护骨因子的表达和分泌而发挥作用的。 相似文献
998.
Manasco PK; Umbach DM; Muly SM; Godwin DC; Negro-Vilar A; Culler MD; Underwood LE 《Human reproduction (Oxford, England)》1997,12(10):2108-2114
We measured luteinizing hormone (LH) and follicle stimulating hormone (FSH)
by immunofluorometric assays and alpha-inhibin by radioimmunoassay in serum
sampled every 10 min throughout the night (2100-0500 h) from 44 normal
girls. Mean overnight LH values rose log- linearly from a mean of 0.2 IU/l
in prepubertal girls to 3.0 IU/l in late pubertal girls. Log2 mean
overnight FSH rose rapidly through early puberty and then remained
constant; mean FSH rose from 1.0 IU/l in prepubertal girls to approximately
2.8 IU/l in Tanner III-V girls. Mean overnight inhibin increased through
puberty, rising from 151 ng/l in prepubertal girls to 432 ng/l in fully
pubescent girls. Within each of the first three Tanner stages, LH differed
approximately 100-fold between the smallest and largest mean concentrations
but differed <10- fold within stages IV or V. Such within-pubertal stage
variability was less pronounced for FSH, which differed approximately
16-fold among Tanner I subjects and 4-10-fold at later stages, and for
inhibin, which varied approximately 4-fold within each Tanner stage. The
frequency of LH pulses during overnight sampling increased significantly
during puberty, but the frequency of FSH and inhibin pulses remained
constant. We compared the results from girls to those from 50 normal boys
[Manasco et al. (1995) J. Clin. Endocrinol. Metab., 80, 20462052]. At each
pubertal stage, girls had approximately the same mean overnight LH values
as boys; girls had higher mean overnight FSH, particularly during Tanner
stages II-IV; and boys had mean overnight alpha-inhibin immunoreactivity
approximately 1.5 times that of girls at each pubertal stage. Still,
hormone concentrations for individuals of both sexes intergraded at each
pubertal stage.
相似文献
999.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS 《International immunology》1997,9(11):1745-1755
1000.